Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical muscle regeneration and satellite cell activation research contexts
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma
[Ingredients] Purified water, propanediol, glycereth-26, isopentyldiol, glycerin, butylene glycol, 1,2-hexanediol, niacinamide, polyglycerin-3, carbomer, ammonium acryloyldimethyltaurate/VP copolymer, tromethamine, canola oil, polyglyceryl-10 laurate, helianthus annuus (sunflower) seed oil, polyglyceryl-4 laurate, dipropylene glycol, betaine, meadowfoam seed oil, polyglyceryl-10 stearate, argania kernel oil, fragrance, adenosine, disodium EDTA, sodium polyacrylate, sodium hyaluronate, glyceryl acrylate/acrylic acid copolymer, PVM/MA copolymer, glutathione (50 ppm), sodium surfactin, Lactobacillus/Soybean Ferment Extract, Lactobacillus/Rice Ferment, Lactobacillus/Ginseng Root Ferment Filtrate, Yeast/Coix Seed Ferment Filtrate, Yeast/Potato Extract Ferment Filtrate, Sodium DNA, Artichoke Leaf Extract, Ethylhexylglycerin, Hydrolyzed Hyaluronic Acid, Hydroxypropyltrimonium Hyaluronate, Rosa Damascena Flower Extract, Pentylene Glycol, Sodium Hyaluronate Crosspolymer, Sodium Acetylated Hyaluronate, SH-Oligopeptide-1 (0.01 PPM)
Both LC and R groups were recruited ~12 months after the onset of SARS-CoV-2 infection ( Supplementary Table 1 )
SARS-CoV-2 has been reported to markedly decrease the level of GSH 146
